Celebrex: Targeted Relief for Osteoarthritis and Rheumatoid Arthritis
Celebrex
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.00 (0%) | 🛒 Add to cart |
| 90 | $0.70 | $73.50 $63.00 (14%) | 🛒 Add to cart |
| 120 | $0.63 | $98.00 $76.00 (22%) | 🛒 Add to cart |
| 180 | $0.58 | $147.00 $104.00 (29%) | 🛒 Add to cart |
| 270 | $0.54 | $220.50 $147.00 (33%) | 🛒 Add to cart |
| 360 | $0.53
Best per pill | $294.00 $189.00 (36%) | 🛒 Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.40 | $42.00 (0%) | 🛒 Add to cart |
| 60 | $0.98 | $84.00 $59.00 (30%) | 🛒 Add to cart |
| 90 | $0.84 | $126.00 $76.00 (40%) | 🛒 Add to cart |
| 120 | $0.78 | $168.00 $93.00 (45%) | 🛒 Add to cart |
| 180 | $0.72 | $252.00 $129.00 (49%) | 🛒 Add to cart |
| 270 | $0.66 | $378.00 $179.00 (53%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $504.00 $232.00 (54%) | 🛒 Add to cart |
Synonyms
| |||
Celebrex (celecoxib) is a prescription nonsteroidal anti-inflammatory drug (NSAID) classified as a COX-2 selective inhibitor. It is specifically designed to manage pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis in adults. Unlike traditional NSAIDs, which inhibit both COX-1 and COX-2 enzymes, Celebrex selectively targets the COX-2 enzyme responsible for inflammation and pain, thereby potentially reducing the risk of gastrointestinal ulcers and bleeding. It is also approved for the management of acute pain and primary dysmenorrhea. Celebrex represents a significant advancement in NSAID therapy, offering effective symptomatic control with a tailored mechanism of action.
Features
- Active ingredient: Celebrex 100 mg, 200 mg, and 400 mg capsules containing celecoxib
- Drug class: Selective cyclooxygenase-2 (COX-2) inhibitor
- Prescription status: Rx-only medication
- Formulation: Oral capsules with immediate-release properties
- Manufacturer: Pfizer Inc.
- FDA approval: Initially approved December 31, 1998
- Bioavailability: Approximately 99% when taken with high-fat food
- Half-life: Approximately 11 hours in healthy adults
- Metabolism: Primarily hepatic via cytochrome P450 2C9 (CYP2C9)
- Excretion: Mainly fecal (57%) with renal elimination (27%)
Benefits
- Provides effective relief from chronic inflammatory pain associated with arthritis conditions
- Reduces joint stiffness and improves physical function in osteoarthritis and rheumatoid arthritis patients
- Lower incidence of gastrointestinal ulcers and bleeding compared to non-selective NSAIDs
- Convenient once or twice-daily dosing regimen improves medication adherence
- Does not interfere with platelet aggregation, eliminating aspirin-like antiplatelet effects
- Demonstrated efficacy in reducing inflammatory markers and pain scores in clinical trials
Common use
Celebrex is primarily prescribed for the management of osteoarthritis (OA) and rheumatoid arthritis (RA) in adults. For osteoarthritis, it helps reduce joint pain, stiffness, and swelling, thereby improving mobility and quality of life. In rheumatoid arthritis, it serves as a symptomatic treatment to control inflammation and pain as part of a comprehensive management strategy. Additionally, Celebrex is used for ankylosing spondylitis to reduce pain and improve spinal mobility. Off-label uses sometimes include management of acute gout attacks and pain control following surgical procedures, though these applications require careful physician consideration.
Dosage and direction
For osteoarthritis: The recommended dose is 200 mg per day administered as a single dose or as 100 mg twice daily. For rheumatoid arthritis: The recommended dose is 100 mg to 200 mg twice daily. For ankylosing spondylitis: The recommended dose is 200 mg once daily or 100 mg twice daily. If no effect is observed after 6 weeks, a trial of 400 mg daily (200 mg twice daily) may be considered. For acute pain and primary dysmenorrhea: The recommended initial dose is 400 mg, followed by an additional 200 mg dose if needed on the first day. On subsequent days, the recommended dose is 200 mg twice daily as needed. Celebrex should be taken with a full glass of water and may be administered with or without food, though taking with food may decrease the incidence of gastrointestinal upset. The lowest effective dose should be used for the shortest duration consistent with individual treatment goals.
Precautions
Patients should be monitored for signs and symptoms of gastrointestinal ulceration and bleeding, even in the absence of previous GI symptoms. Celebrex may cause serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. The risk may increase with duration of use and in patients with cardiovascular disease or risk factors. Celebrex can lead to new hypertension or worsening of pre-existing hypertension, requiring blood pressure monitoring during treatment. Fluid retention and edema have been reported with NSAID use, and Celebrex should be used with caution in patients with fluid retention, heart failure, or hypertension. Hepatic effects including elevated liver enzymes and rare cases of severe hepatic reactions have been reported. Renal toxicity including papillary necrosis and other renal injury can occur. Patients should be advised to stay well-hydrated during treatment. Celebrex may cause serious skin reactions including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis.
Contraindications
Celebrex is contraindicated in patients with known hypersensitivity to celecoxib or any component of the drug formulation. It should not be used in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs, as severe anaphylactic reactions may occur. Celebrex is contraindicated in the setting of coronary artery bypass graft (CABG) surgery due to increased risk of myocardial infarction and stroke. It should not be used during the third trimester of pregnancy as it may cause premature closure of the ductus arteriosus. Patients with a history of gastrointestinal bleeding associated with NSAID use should avoid Celebrex. Those with severe hepatic impairment (Child-Pugh Class C) should not use Celebrex.
Possible side effect
Common side effects (≥2%) include: dyspepsia (8.8%), diarrhea (5.6%), abdominal pain (4.1%), nausea (3.5%), flatulence (2.2%), peripheral edema (2.1%), dizziness (2.0%), headache (15.8%), insomnia (2.3%), and rash (2.2%). Less common but serious side effects include: gastrointestinal bleeding and perforation, cardiovascular thrombotic events, hypertension, heart failure, renal toxicity and failure, hepatotoxicity including fatal hepatitis, anaphylactic reactions, serious skin reactions, hematological effects including anemia, and exacerbation of asthma. Patients should seek immediate medical attention for signs of allergic reactions (difficulty breathing, swelling of face or throat), chest pain, weakness on one side of the body, slurred speech, black or bloody stools, vomiting blood, skin rash, unexplained weight gain, or decreased urine output.
Drug interaction
Celebrex interacts with several medication classes. Concomitant use with aspirin may increase the risk of GI bleeding. Fluconazole administration increases celecoxib concentrations approximately two-fold due to inhibition of CYP2C9. Lithium levels may increase when taken with Celebrex, requiring monitoring. Celebrex may enhance the effects of warfarin and increase the risk of bleeding; prothrombin time should be monitored. Concomitant administration with ACE inhibitors, angiotensin receptor blockers, or diuretics may reduce the antihypertensive effect and increase renal impairment risk. Celebrex may decrease the effectiveness of SSRIs in preventing platelet aggregation. Concomitant use with other NSAIDs should be avoided due to increased risk of adverse effects. Celebrex may interfere with the natriuretic effect of furosemide and thiazides.
Missed dose
If a dose of Celebrex is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one. Consistency in dosing helps maintain stable drug levels for optimal pain control. If multiple doses are missed or there is uncertainty about dosing, patients should consult their healthcare provider for guidance. Setting daily reminders or using pill organizers can help prevent missed doses, especially for patients on twice-daily regimens.
Overdose
Symptoms of Celebrex overdose may include lethargy, drowsiness, nausea, vomiting, epigastric pain, gastrointestinal bleeding, hypertension, acute renal failure, respiratory depression, coma, and anaphylactic reactions. There is no specific antidote for celecoxib overdose. Management should be supportive and symptomatic. Gastric lavage or administration of activated charcoal may be considered if performed soon after ingestion. Hemodialysis is not effective for removing celecoxib due to its high protein binding. Forced diuresis, alkalinization of urine, or hemoperfusion may not be useful due to high protein binding. Supportive care should include monitoring of vital signs and observation for signs of gastrointestinal bleeding, renal failure, and other adverse effects. Symptomatic treatment for specific organ system involvement should be instituted as appropriate.
Storage
Celebrex capsules should be stored at room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept in its original container with the lid tightly closed to protect from moisture and light. Celebrex should be kept out of reach of children and pets to prevent accidental ingestion. Do not store in bathrooms or other areas with high humidity. Unused or expired medication should be disposed of properly through medication take-back programs or according to FDA guidelines. Do not flush medications down the toilet unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Celebrex is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual response to medication may vary, and the benefits and risks should be carefully considered for each patient. This information is not exhaustive and does not include all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Patients should consult with their healthcare provider for complete information about their specific medical condition and treatment options. The manufacturer’s prescribing information should be consulted for complete details.
Reviews
Clinical studies have demonstrated Celebrex’s efficacy in arthritis management. In a 12-week osteoarthritis study, Celebrex 100 mg twice daily and 200 mg once daily showed significant improvement in pain and physical function compared to placebo. For rheumatoid arthritis, Celebrex 200 mg twice daily demonstrated significant improvement in the number of tender and swollen joints compared to placebo. Patient reviews often highlight improved mobility and reduced morning stiffness, though some report gastrointestinal discomfort despite the COX-2 selectivity. Many patients appreciate the once-daily dosing convenience compared to other NSAIDs requiring more frequent administration. Some reviews note concerns about cardiovascular risks, reflecting increased patient awareness of NSAID safety profiles. Overall satisfaction appears higher among patients who have experienced GI complications with traditional NSAIDs.